BMS 100 mg 3623
Generic Name: atazanavir
Pill imprint BMS 100 mg 3623 has been identified as Reyataz 100 mg.
Reyataz is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy.
Reyataz 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Reyataz Images
- Generic Name:
- atazanavir
- Imprint:
-
BMS 100 mg
3623 - Strength:
- 100 mg
- Color:
- Blue & White
- Size:
- 18.00 mm
- Availability:
- Prescription only
- Inactive Ingredients:
- crospovidone
lactose monohydrate
magnesium stearate
gelatin
FD&C Blue No. 2
titanium dioxide
ferric oxide red
ferric oxide yellow
isopropyl alcohol
ammonia
propylene glycol
butyl alcohol
alcohol
ferrosoferric oxide
shellac
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00003-3623
Advertisement
More Reyataz resources
Search Again
